Physician profile
Michelle M Andre
NPI 1487873428
$3,623.87
in general payments reported to CMS, 2019-2025
28 companies · $191 in 2025
The $191 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,481 · 2020: $348 · 2021: $415 · 2022: $587 · 2023: $497 · 2024: $106 · 2025: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $619 · Education: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $618.94 |
| Education | $175.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,306.04 | 2019-2021 | |
| Abbvie INC. | $405.95 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Exeltis, USA INC. | $359.23 | 2020-2025 | Slynd |
| Astellas Pharma US INC | $245.84 | 2023-2025 | Veozah |
| Avion Pharmaceuticals | $157.73 | 2020-2023 | Balcoltra |
| Merz North America, INC. | $150.17 | 2022 | |
| Pfizer INC. | $101.64 | 2019-2021 | |
| Hologic Sales and Service, LLC | $85.30 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $82.11 | 2022-2023 | |
| Therapeuticsmd, INC. | $73.49 | 2019-2021 | |
| Allergan, INC. | $72.31 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $66.23 | 2019-2022 | |
| Millicent US INC | $64.44 | 2020-2024 | Intrarosa, Femring |
| Evofem Biosciences, INC. | $62.23 | 2021-2025 | Solosec, Phexx, Phexxi |
| Organon LLC | $61.55 | 2021-2023 | Nexplanon |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $50.81 | 2019-2022 | |
| Lupin INC. | $47.54 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $47.15 | 2021 | |
| Merck Sharp & Dohme LLC | $30.94 | 2019-2020 | |
| Coloplast Corp | $22.15 | 2025 | |
| Exact Sciences Corporation | $20.15 | 2025 | The Cologuard Plus Collection Kit |
| Scynexis, INC. | $18.10 | 2021 | |
| Radius Health, INC. | $17.49 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $17.03 | 2019 | |
| Sumitomo Pharma America, INC. | $17.02 | 2023 | Gemtesa |
| Lilly USA, LLC | $15.70 | 2020 | |
| Duchesnay USA Incorporated | $13.14 | 2019 | |
| Coopersurgical, INC. | $12.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Andre listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.